pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
LEADING · news · pharmadog
← back to LEADING
News mentioning LEADING
651
stories
14d
The Trump administration is doubling down on health care fraud investigations
stat
14d
Virginia leads in winning investments as drugmakers onshore to the US
endpoints
14d
Mass. lawmaker Auchincloss favors boosting U.S. biotech over targeting China
stat
15d
Osivax pivots to combo approach after flu jab fails in Phase 2b
endpoints
15d
Webinar: The China question: Can US biotechs lead as investment heads east?
biospace
15d
OrbiMed raises $3B in new life sciences funds, including $1B+ for Asia
endpoints
15d
OrbiMed’s largest-ever Asian fund contributes to $3B war chest
fiercebiotech
15d
Opinion: MyChart said I could opt out of sharing my health data. Figuring out how was maddening
stat
15d
Estuary flows out of stealth with $103M to propel kidney disease gene therapies into clinic
fiercebiotech
15d
AstraZeneca inks $1.5B insitro deal for AI-enabled target discovery of liver, heart disease drugs
fiercebiotech
15d
Former FDA officials blast DOGE as ‘one of the biggest disasters in American history’
stat
15d
As White House shifts focus toward AI and tech, U.S. science leaders defend role of the American university
stat
16d
Zealand pens up to $1.2B deal with Generate for AI-designed obesity, metabolic drugs
biospace
16d
Jazz CEO calls on industry to help rebuild momentum for leadership diversity
biospace
16d
Infusion Set Recall: BD and CareFusion 303, Inc. Remove BD Alaris Pump Infusion Sets
fda medwatch
16d
Agilent spends $240M upfront to buy digital pathology specialist Proscia
fiercebiotech
16d
Helen Branswell, whose reporting on infectious diseases and public health drew acclaim, dies at 69
stat
17d
Rudy Tanzi has long wanted to prevent Alzheimer's. He may be close
endpoints
17d
STAT+: Pharmalittle: We’re reading about concerns over a rare disease drug, pharma payments to docs, and more
stat
17d
Syndax ends fibrosis program for Niktimvo after mid-stage disappointment
biospace
17d
Saudi Arabia takes actionable steps to build its biotech sector after 46 agreements in Riyadh
fiercebiotech
18d
Bristol Myers dips on ‘confounding’ lung drug results
biopharma dive
18d
Brent Saunders out as Bausch + Lomb CEO, an abrupt end to three-year run
endpoints
18d
How to boost throughput and data quality for stability testing of biologics
biospace
19d
Americans trust science more than peers around the world, survey shows
stat
20d
Women in Biopharma 2026; A secretive new thorn in pharma’s side; and more
endpoints
20d
STAT+: Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role
stat
20d
STAT+: Pharma’s free lunches for doctors boost inappropriate prescribing, analysis finds
stat
21d
TRexBio, Retension raise $161.7M in IPOs; City, Iambic set proposed offering terms
biospace
21d
Pfizer pens $500M Enodia pact to join Lilly in emerging protein degrader field
fiercebiotech
← prev
page 3 of 22
next →
